Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients—STAT Study

医学 门冬氨酸胰岛素 胰岛素 麻醉 连续血糖监测 内科学 泌尿科 外科 低血糖 血糖性
作者
Janet K. Snell‐Bergeon,Halis Kaan Aktürk,Amanda Rewers,Bruce W. Bode,Leslie J. Klaff,Anne L. Peters,Timothy S. Bailey,Satish K. Garg
出处
期刊:Diabetes [American Diabetes Association]
卷期号:67 (Supplement_1) 被引量:1
标识
DOI:10.2337/db18-1017-p
摘要

Sixty patients with T1D on multiple daily injections (MDI) were randomized in a multi-center study, stratified by A1c values (<8.5% or ≥ 8.5%) to the control arm using aspart (n=34) vs. TI group (n=26). Patients in the TI arm were advised to take extra inhalations at 1 and 2 hours after meals based on post-prandial blood glucose (PPBG) values. Baseline characteristics and FEV1 were similar. Using per protocol (PPT) analysis, we examined outcomes over the 4-week period using linear regression with repeated measures. The primary outcomes were TIR (70-180 mg/dL) and PPBG excursions. Compliance with TI was based on its use when indicated at 1- and 2-hour PPBG. Patients with at least 80% compliance were included in PPT (n=15). Seven TI patients were non-compliant; 2 dropped out of the study; and 2 did not have CGM data. CGM glucose patterns and TIR for a patient with 100% or with 56% compliant with TI are shown (Figure 1a and 1b). TIR was significantly higher in the TI-compliant group compared to control or TI-non-compliant groups (Figure 1c). PPBG was also significantly lower in the TI-compliant compared to the control group at 1- and 2-hours post-prandial but not at 3 and 4 hours. PPBG was significantly lower in the compliant vs. non-compliant TI group at all time points (Figure 1d). We conclude that TI improves TIR and PPBG values, if patients use additional inhalations as directed. Disclosure J.K. Snell-Bergeon: Stock/Shareholder; Self; Abbott. Research Support; Self; Roche Diagnostics Corporation. H.K. Akturk: None. A. Rewers: None. B.W. Bode: Research Support; Self; Abbott. Advisory Panel; Self; ADOCIA. Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc.. Consultant; Self; Janssen Pharmaceuticals, Inc.. Research Support; Self; GlaxoSmithKline plc., Lexicon Pharmaceuticals, Inc., Medtronic MiniMed, Inc., Novo Nordisk Inc., Diasome Pharmaceuticals, Inc., Sanofi US, Eli Lilly and Company, MannKind Corporation, Dexcom, Inc., OmniPod, Senseonics. L.J. Klaff: Research Support; Self; Abbott, Intarcia Therapeutics, Inc., MannKind Corporation, Dexcom, Inc., Novartis Pharmaceuticals Corporation, Gelesis, Novo Nordisk Inc., Eli Lilly and Company, Medtronic, Sanofi. A. Peters: Advisory Panel; Self; Abbott, Bigfoot Biomedical. Research Support; Self; Dexcom, Inc.. Advisory Panel; Self; Eli Lilly and Company, Insulin Algorithms, JDRF, Lexicon Pharmaceuticals, Inc., Livongo Health. Research Support; Self; MannKind Corporation. Other Relationship; Self; Medscape. Advisory Panel; Self; Merck & Co., Inc.. Research Support; Self; National Institute of Diabetes and Digestive and Kidney Diseases. Speaker's Bureau; Self; Novo Nordisk Inc.. Advisory Panel; Self; Novo Nordisk Inc., Omada Health, Inc., Optum Rx, Inc., Sanofi. Research Support; Self; T1D Exchange. Advisory Panel; Self; The Endocrine Society. Research Support; Self; The Leona M. and Harry B. Helmsley Charitable Trust. Advisory Panel; Spouse/Partner; Johnson & Johnson Diabetes Institute, LLC. T.S. Bailey: Research Support; Self; Abbott. Consultant; Self; Abbott. Speaker's Bureau; Self; Abbott. Research Support; Self; Ambra BioScience, Ascensia Diabetes Care, Becton, Dickinson and Company. Consultant; Self; Becton, Dickinson and Company. Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc., Calibra Medical. Consultant; Self; Calibra Medical. Research Support; Self; Companion Medical, Dexcom, Inc., Glooko, Inc., GlySens Incorporated, Lexicon Pharmaceuticals, Inc., Eli Lilly and Company. Consultant; Self; Eli Lilly and Company. Speaker's Bureau; Self; Eli Lilly and Company. Research Support; Self; Medtronic MiniMed, Inc.. Consultant; Self; Medtronic MiniMed, Inc.. Speaker's Bureau; Self; Medtronic MiniMed, Inc.. Research Support; Self; Novo Nordisk Inc.. Consultant; Self; Novo Nordisk Inc.. Speaker's Bureau; Self; Novo Nordisk Inc.. Research Support; Self; Sanofi. Consultant; Self; Sanofi. Speaker's Bureau; Self; Sanofi. Research Support; Self; Senseonics. Consultant; Self; Intarcia Therapeutics, Inc.. Research Support; Self; Versartis, Inc., Xeris Pharmaceuticals, Inc., MannKind Corporation. S.K. Garg: Research Support; Self; Dexcom, Inc., Eli Lilly and Company, Sanofi US. Advisory Panel; Self; Sanofi US. Research Support; Self; MannKind Corporation, Diasome Pharmaceuticals, Inc., Labstyle Innovations, Lexicon Pharmaceuticals, Inc., Medtronic. Advisory Panel; Self; Novo Nordisk A/S.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
sunnio完成签到,获得积分10
刚刚
Ivan完成签到 ,获得积分10
刚刚
1秒前
bioglia完成签到,获得积分10
1秒前
林翔翔发布了新的文献求助10
2秒前
3秒前
彪壮的向松完成签到,获得积分10
4秒前
单调完成签到 ,获得积分10
4秒前
mingjie完成签到,获得积分10
4秒前
细腻听寒完成签到,获得积分10
4秒前
科研顺发布了新的文献求助10
4秒前
5秒前
酷波er的应助被谨慎的秋烟采纳,获得10
5秒前
wt驳回了wanci的应助
5秒前
Xenophobia的应助被秋月春风采纳,获得30
5秒前
7秒前
7秒前
DW的应助被michael采纳,获得10
7秒前
8秒前
脑洞疼的应助被gtx采纳,获得10
9秒前
清爽荣轩完成签到 ,获得积分10
9秒前
陶醉的寄翠完成签到,获得积分20
9秒前
孙嘉畯发布了新的文献求助10
9秒前
彭于晏的应助被hanyunlu采纳,获得10
10秒前
酷波er的应助被jovywhoo@163.com采纳,获得10
11秒前
所所的应助被DW采纳,获得10
11秒前
11秒前
11秒前
12秒前
12秒前
魔真人发布了新的文献求助10
12秒前
隐形曼青的应助被平淡的忆之采纳,获得10
12秒前
吴糖完成签到,获得积分10
12秒前
13秒前
bodao完成签到,获得积分10
13秒前
我想静静发布了新的文献求助10
13秒前
clamdown发布了新的文献求助10
13秒前
小蘑菇的应助被数星星的薯片采纳,获得10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Stochastic Models in Operations Research,Vol. 2 600
Guidelines for fracture-safe and fatigue-reliable design of steel structures 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8026680
求助须知:如何正确求助?哪些是违规求助? 9467753
关于积分的说明 21228365
捐赠科研通 7597375
什么是DOI,文献DOI怎么找? 3387589
关于科研通互助平台的介绍 2520164
邀请新用户注册赠送积分活动 2424004